Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × ABT-414 × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Doxorubicin 37 Vincristine 25 Radiotherapy 25 Ifosfamide 25 Cyclophosphamide 21 Etoposide 18 Imatinib Mesylate 17 Radiation 12 Dactinomycin 12 Filgrastim 11 Temozolomide 9 Trabectedin 8 Sunitinib 8 Methotrexate 8 Specimen Handling 6 Granulocyte Colony-Stimulating Factor 6 pazopanib 5 Zoledronic Acid 5 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Cisplatin 5 nilotinib 4 Topotecan 4 Surgical Procedures, Operative 4 Procarbazine 4 Paclitaxel 4 Liposomes 4 Ibandronic Acid 4 Dexrazoxane 4 Cytarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02573324 2023-05-11

Intellance1

AbbVie

Phase 3 Completed

691 enrolled 28 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡